Dr. C.H.J. Lamers

Update Persondata

• alpha
• antibodies
• cancer
• cell
• cells
• gene
• immune
• patients
• plasma
• receptor
• risk
• stem
• treatment
• tumor

Publications

(the most recent at the top)

Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials

Circulating endothelial cells in oncology: Pitfalls and promises

Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibody

Completed research projects

(the most recent research is at the top)
Project leader	Immune monitoring of experimental biological anti-tumor therapies
Project leader	Clinical immune and gene therapy against tumors